Health Net
Esbriet (pirfenidone)
Drugs for the Lungs : Drugs for the Lungs
  • Health Net Approved Indications and Usage Guidelines: 1. Diagnosis of Idiopathic Pulmonary Fibrosis (IPF). AND 2. Prescribed by or in consultation with a pulmonologist. Authorization Limit: Length of benefit.
  • Limited Access. Must use Exactus Specialty Rx.
  • Prior Authorization: Idiopathic Pulmonary Fibrosis (IPF):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • Idiopathic Pulmonary Fibrosis (IPF):
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): Pulmonologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Policy requires patient to be non-smoker: Yes
    Evidence required for non-smoker: Yes
    FVC % Value in Policy: >= 50
    Carbon Monoxide Diffusion Capacity (DLCO): N/A
    Patient Must Not Have End Stage Renal Disease (ESRD) or Severe Hepatic Impairment: No
    Reapproval criteria includes that the patient has less than 10% decrease in FVC: No
    ESRD or severe hepatic impairment criteria: No